Doctors are leaving to work in Australia, GP warns

UK primary care is facing escalating workforce pressure as a GP warns of a 'huge exodus' of young doctors to Australia; the General Medical Council reported a 19% rise in doctors leaving in 2024, from 1,350 in 2023 to 1,604. Pay differentials (first‑year doctors cited at ~£47,530 in Australia vs ~£38,831 in the UK) and burnout are key drivers; the Department for Health and Social Care has pledged an extra £1.1bn to primary care and says 2,500 GPs were recruited since Labour took power, with GP targets halved. Continued outflows risk service disruption, increased operating pressures and potential higher costs for the NHS, with knock‑on implications for healthcare delivery and public finances.

Analysis

Market structure: The 19% rise in doctors leaving and a ~23% pay gap (AU £47.5k vs UK £38.8k cited) creates immediate winners — private/hospital operators and staffing agencies able to deploy locums (e.g., SPI.L, AMN, HCA) — and losers — underfunded GP surgeries and NHS primary-care contractors facing higher replacement costs and service gaps. Expect upward pressure on UK locum pay and contracted staffing margins for 3–12 months; private providers with scale can monetise shortages and command pricing power in the near term.

Risk assessment: Tail risks include a policy counterreaction (Labour increasing pay/funding by >£1.5–2.0bn within 60–90 days), abrupt Australian visa tightening, or coordinated strike action that materially changes flows. Immediate (days) impact is sentiment and FX; short-term (weeks–months) raises staffing costs and bond issuance risk; long-term (2–5 years) depends on training pipeline and return rates of younger doctors historically seen to revert.

Trade implications: Positioning should overweight listed private healthcare and global staffing (2–3% core long SPI.L; 2% long AMN; 1–2% long HCA) while expressing macro via short UK 10-year gilt futures sized to target portfolio duration +0.25–0.5y exposure (3–12 month view). Use options: buy 3–6 month call spreads on SPI.L and AMN to cap cost and buy a 3–9 month put spread on long-dated UK gilt futures anticipating higher yields. FX: tactical short GBP/AUD (0.5–1% NAV) over 3–6 months expecting persistent UK wage/politics pressure.

Contrarian angles: Consensus underestimates reversibility — many junior doctors historically return within 1–3 years, so private valuations could be overstretched if departure rate reverts below 10% yoy. Watch two thresholds to flip trades: (1) if GMC departures >25% yoy persist for two consecutive quarters, increase healthcare staffing longs; (2) if DHSC announces >£2bn new funding or binding pay deals within 60 days, reduce gilt shorts and trim private hospital longs by 50%.

Key Decisions for Investors

• Establish a 2–3% NAV long in Spire Healthcare (SPI.L) on expectation of higher elective/private demand and locum utilisation for the next 3–12 months; hedge operational risk with a 3–6 month call spread (buy ATM, sell 10–15% OTM).
• Allocate 2% NAV long to AMN Healthcare (AMN) or equivalent global medical staffing (US-listed) to capture higher international locum demand; size to earn a target IRR assuming a 5–10% revenue uplift over 6–12 months.
• Open a tactical short on UK 10-year gilt futures (size duration +0.25–0.5y) for a 3–12 month horizon; implement a 3–9 month put spread on long-dated gilt futures as a defined-cost way to profit from yield rises if government spending on pay increases but funding gaps widen.
• Initiate a 0.5–1% NAV short GBP/AUD spot (or buy GBP/AUD puts, 3–6 month expiry) to capture differential labour-market-driven pressure on GBP; cut position if GBP/AUD rallies >2% or Australian visa rules tighten materially.
• Set hard monitoring triggers: if DHSC announces additional primary-care funding >£1.5bn within 30–60 days or a permanent pay uplift that exceeds 10% for GPs, reduce gilt shorts by 50% and trim SPI.L/AMN exposure by 25% to limit policy-reversal risk.